EE437 Healthcare Resource Utilization and Costs in Patients with Multiple Myeloma Who Received 1 to 3 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and Exposed to (AND DISCONTINUED) Lenalidomide in the ...
Abstract
Authors
S Jagannath N Joseph E Chinaeke C Crivera A Fu A Garrett N Shah